FDA weighs broad labeling revisions for prescription drugs
The FDA considers major changes to labeling on prescription drugs to help doctors compare products, curb excessive advertising, and standardize warnings. Proposals include clearer pregnancy risks, drug interaction alerts, and restricted promotional claims, with potential disruptions to medical practice and industry pushback.